A Phase III Randomized Double-Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Phase of Trial: Phase III
Latest Information Update: 03 Sep 2016
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Romark Laboratories
- 24 Aug 2016 Status changed from recruiting to completed.
- 26 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 27 Nov 2015 New trial record